Description

LDL apheresis can be used to lower blood LDL particles in selected patients with familial hypercholesterolemia (FH).


LDL apheresis is considered when both of the following are present:

(1) the patient fails to achieve an adequate response after >= 6 months of maximum tolerated drug therapy

(2) the patient shows certain patterns of laboratory and clinical findings

 

Parameters:

(1) type of FH

(2) serum cholesterol concentration

(3) risk factors (elevated blood pressure, smoking, obesity, physical inactivity, unhealthy diet)

 

Very high risk factors:

(1) established coronary artery disease

(2) other established vascular disease

(3) diabetes

 

Type of FH

Cholesterol in mg/dL

Risk Factors

functional homozygous

LDL-C >= 300

NA

functional homozygous

non-HDL-C >= 330

NA

functional heterozygous

LDL-C >= 300

0 or 1

functional heterozygous

non-HDL-C >= 330

0 or 1

functional heterozygous

LDL-C >=200

>= 2 or high lipoprotein(a)

functional heterozygous

non-HDL-C >= 230

>= 2 or high lipoprotein(a)

functional heterozygous

LDL-C >=160

very high risk

functional heterozygous

non-HDL-C >= 190

very high risk

 

where:

• A high lipoprotein(a) concentration is >= 50 mg/dL using an isoform insensitive assay.


To read more or access our algorithms and calculators, please log in or register.